This announcement is a separate document:
上海市方达律师事务所关于上海复旦张江生物医药股份有限公司2021年限制性股票激励计划调整、部分限制性股票作废及首次授予部分第一个归属期归属条件成就及相关事项的法律意见书
Legal opinion of Shanghai Fangda Law Firm on the adjustment of the 2021 restricted stock incentive plan of Shanghai Fudan Zhangjiang Biomedical Co., Ltd., the abolition of some restricted shares, and the achievement of vesting conditions for the first vest
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated